Philippe Beutels holds Bachelor and Master degrees in Commercial Engineering (1993), and a PhD in Medical Sciences (2002), both from the UAntwerpen. He also studied econometrics at the University Paris1-Panthéon-Sorbonne (1993-1994), was a postdoctoral senior research fellow at the University of Sydney (2003-2005), a visiting scholar at the University of Technology at Sydney (UTS) (2003-2005), an honorary Associate at the University of Sydney (2005-2010), and is a visiting Senior Fellow at the University of New South Wales, Australia (since 2010). He published over 200 A1 articles, 2 books and a range of other publications, including dozens of government policy reports for various countries. He delivered over 200 lectures and oral communications at scientific symposia, mainly on topics related to health economics, mathematical modelling and epidemiology. He’s the most cited health economist working in Belgium, and globally one of the most prolific authors on the subject of the economics of infectious diseases and vaccines (ISI Web of Science citations > 4800; H-index: 35; Google Scholar citations > 8000; H-index: 43). He was the first recipient of a prize for health economics research awarded by the Royal Academy in Belgium, in 2017. He’s currently Full Professor at the UAntwerpen, Belgium, where he incepted the Centre for Health Economics Research & Modelling Infectious Diseases (CHERMID) in 2007. In 10 years’ time he rapidly developed CHERMID from a single person research unit into a 14 researcher (5 Professors, 2 postdocs and 7 PhD students) strong internationally acclaimed multidisciplinary centre (economics, medicine, mathematics, statistics, philosophy, informatics, physics, biology and bioengineering). CHERMID is funded >90% from external competitive research grants, including current ERC grant holder Niel Hens. Beutels is a frequent adviser for the World Health Organization (WHO), including as a member of pivotal WHO committees, such as the Immunization and Vaccines related Implementation Research Advisory Committee (IVIR-AC). He also chaired several consultations at WHO HQ (eg, on the economics of influenza (2015); influenza costing tools (2015), the Broader Economic Impact on Vaccines and Immunization Programmes (2012), and the IVIR-AC ad interim (2016)). He’s the main senior author of the WHO guide on economic evaluation of vaccines, as well as the 2018 update of this guide, and several other frequently cited methodological guidance documents. Beutels has attracted research funding of over €10 million at UAntwerpen. He led workpackages on “economic evaluation” of several successful European projects, including POLYMOD (2004-2008): “Improving Public Health Policy in Europe through the Modelling and Economic Evaluation of Interventions for the Control of Infectious Diseases”, SARSCONTROL (2005-2008): “Effective and Acceptable Strategies for the Control of SARS and new emerging infections in China and Europe”, the ECDC network “European Surveillance of Antimicrobial Consumption” (2008-2011), and “RESCEU” REspiratory Syncytial virus Consortium in EUrope (2017-2021).